SCHEMBL167053

SCHEMBL167053

COc1ccc(OC)c(NC(N)=O)c1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.67
TP53 P04637 1/20 0.67
KMT2A Q03164 5/20 0.65
NPSR1 Q6W5P4 2/20 0.65
MEN1 O00255 4/20 0.64
HTT P42858 1/20 0.62
MAPT P10636 4/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
ALDH1A1 P00352 4/20 0.60
HPGD P15428 3/20 0.60
POLB P06746 1/20 0.60
KDM4E B2RXH2 2/20 0.59
TSHR P16473 1/20 0.59
HSD17B10 Q99714 1/20 0.59
NPC1 O15118 1/20 0.58
MAPK1 P28482 1/20 0.58
RAB9A P51151 1/20 0.58
HSP90AA1 P07900 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29757951 0.86 ALDH1A1 (0.71) GAAKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL5317475 0.86 ALDH1A1 (0.71) GAAKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL19427718 0.86 MAPT (0.79) GAATP53KMT2ANPSR1MEN1
SCHEMBL7760801 0.85 GAA (0.50) GAATP53KMT2ANPSR1MEN1
SCHEMBL6005341 0.84 GAA (0.69) GAATP53KMT2ANPSR1MEN1
SCHEMBL11660471 0.84 MAPT (0.70) GAATP53KMT2ANPSR1MEN1
SCHEMBL2502603 0.84 MAPT (0.71) GAATP53KMT2ANPSR1MEN1
SCHEMBL9036083 0.83 MAPT (0.67) GAATP53KMT2ANPSR1MEN1
SCHEMBL10747461 0.83 PYGL (0.56) GAATP53KMT2ANPSR1MEN1
SCHEMBL29752141 0.83 ALDH1A1 (0.60) GAATP53KMT2ANPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP claimed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO claimed
EP-0235878-A2 Novel compounds BEECHAM GROUP PLC (GB) 1987-09-09 EP claimed
EP-0235878-A2 Novel compounds BEECHAM GROUP PLC (GB) 1987-09-09 EP disclosed